KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Assets (2016 - 2025)

Historic Assets for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $803.2 million.

  • Pacific Biosciences Of California's Assets fell 4461.18% to $803.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $803.2 million, marking a year-over-year decrease of 4461.18%. This contributed to the annual value of $1.3 billion for FY2024, which is 2781.0% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Assets is $803.2 million, which was down 4461.18% from $825.5 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Assets ranged from a high of $2.0 billion in Q3 2021 and a low of $803.2 million during Q3 2025
  • In the last 5 years, Pacific Biosciences Of California's Assets had a median value of $1.7 billion in 2023 and averaged $1.6 billion.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Assets skyrocketed by 57733.37% in 2021, and later crashed by 4845.33% in 2025.
  • Pacific Biosciences Of California's Assets (Quarter) stood at $2.0 billion in 2021, then dropped by 11.95% to $1.8 billion in 2022, then dropped by 1.19% to $1.7 billion in 2023, then fell by 27.81% to $1.3 billion in 2024, then tumbled by 36.28% to $803.2 million in 2025.
  • Its Assets stands at $803.2 million for Q3 2025, versus $825.5 million for Q2 2025 and $860.8 million for Q1 2025.